I would talk to your service provider (the people doing the actual sequencing) about your problems especially in regards to the phiX.
Unconfigured Ad
Collapse
X
-
Hi everyone,
I go back to Pat Schloss: http://blog.mothur.org/2014/09/11/Wh...nce-matrix%3F/
If you don't de-noise properly (ie. fully overlapped reads), you get too many unique sequences. Hence, you end having a huge matrix downstream.
But what has happened in the field during the last year? Are there improved methods to deal with this problem? MadsAlbertsen, which method do you use?Last edited by fibar; 12-15-2015, 12:39 PM.
Comment
-
We have been using the UPARSE workflow for some time now and are in general very happy with it (http://drive5.com/uparse/).
Comment
-
I want to sequence the V4 region using illuminas 16S metagenomic sequencing library preparation protocol (dual indexing approach using nextera indexes). Anyone have experience doing this?
Comment
-
In fact, there IS an improved method for dealing with noise and false-positives. BBMerge has a much lower false-positive merge rate than any other overlap-based read merger, including usearch.Originally posted by fibar View PostBut what has happened in the field during the last year? Are there improved methods to deal with this problem?
Comment
-
Primers and barcodes for V1-V2
Hello,
I was wondering whether any of you has sequenced using Illumina primers for V1-V2 region....Does anyone have a list of barcodes I could used? We need to focus on this region, since it is the best approach to identify sp within oral samples. ...
Many thanks
Elisa
Comment
-
I don't think that question's been answered. But, you might want to look at this paper, which compares V4 to full-length:
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
Today, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 05:39 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
Today, 05:39 AM
|
||
|
Started by SEQadmin2, Yesterday, 09:56 AM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|
||
|
Started by SEQadmin2, 09-29-2026, 09:51 AM
|
0 responses
77 views
0 reactions
|
Last Post
by SEQadmin2
09-29-2026, 09:51 AM
|
Comment